Lineage Cell Therapeutics, Inc. Skyrocketed

Tue, Apr 27, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. Skyrocketed

Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $24.9, a gain of 51.2%. On Mon, Apr 26, 2021, BTX:NYSEMKT touched a New 2-Week High of $16.47. The stock got featured on our News Catalysts scanner on Mon, Apr 26, 2021 at 08:48 AM in the 'MISCELLANEOUS' category. From Mon, Apr 12, 2021, the stock recorded 70.00% Up Days and 54.55% Green Days

About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)

BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.